These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27956461)

  • 21. Elevated urinary dopamine in adults and children.
    Davidson DF
    Ann Clin Biochem; 2005 May; 42(Pt 3):200-7. PubMed ID: 15949155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography-tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis.
    Woo HI; Yang JS; Oh HJ; Cho YY; Kim JH; Park HD; Lee SY
    Clin Biochem; 2016 May; 49(7-8):573-9. PubMed ID: 26779993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cases of dopa-responsive dystonia (Segawa disease) in Estonia.
    Talvik I; Segawa M; Veri K; Gross-Paju K; Talvik T
    Brain Dev; 2010 May; 32(5):428-31. PubMed ID: 19427147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroblastoma and ganglioneuroblastoma: associated increased urinary excretion of catecholamines.
    STICKLER GB; FLOCK EV
    Cancer Chemother Rep; 1962 Feb; 16():439-42. PubMed ID: 13917202
    [No Abstract]   [Full Text] [Related]  

  • 25. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.
    Clot F; Grabli D; Cazeneuve C; Roze E; Castelnau P; Chabrol B; Landrieu P; Nguyen K; Ponsot G; Abada M; Doummar D; Damier P; Gil R; Thobois S; Ward AJ; Hutchinson M; Toutain A; Picard F; Camuzat A; Fedirko E; Sân C; Bouteiller D; LeGuern E; Durr A; Vidailhet M; Brice A;
    Brain; 2009 Jul; 132(Pt 7):1753-63. PubMed ID: 19491146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells.
    Pardo B; Mena MA; de Yébenes JG
    J Neurochem; 1995 Feb; 64(2):576-82. PubMed ID: 7830050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of determination of concentrations of catecholamines and their metabolites in the urine of children with neuroblastoma for diagnostic purposes, control of the course and evaluation of the results of therapy].
    Prokopczyk J; Wańkowicz B; Wenzel E
    Pediatr Pol; 1981 Aug; 56(8):883-8. PubMed ID: 7301482
    [No Abstract]   [Full Text] [Related]  

  • 28. Misdiagnoses in children with dopa-responsive dystonia.
    Jan MM
    Pediatr Neurol; 2004 Oct; 31(4):298-303. PubMed ID: 15464646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Excretion of some catecholamine metabolites in sympathoblastomas].
    PETRASEK J; DUBOVSKY J; VICH Z
    Cas Lek Cesk; 1961 Oct; 100():1335-6. PubMed ID: 14485868
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
    Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
    Vasil'ev VN; Matlina ESh
    Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with paper chromatography of urinary catecholamines in cases of pheochromocytoma and neuroblastoma].
    Zahn H
    Med Welt; 1974 Feb; 25(8):324-9. PubMed ID: 4813944
    [No Abstract]   [Full Text] [Related]  

  • 33. Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.
    McInnes RR; Kaufman S; Warsh JJ; Van Loon GR; Milstien S; Kapatos G; Soldin S; Walsh P; MacGregor D; Hanley WB
    J Clin Invest; 1984 Feb; 73(2):458-69. PubMed ID: 6142058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary progressive dystonia--an observation of the catecholamine metabolism during L-DOPA therapy in a 9-year-old girl].
    Shimoyamada Y; Yoshikawa A; Kashii H; Kihira S; Koike M
    No To Hattatsu; 1986; 18(6):505-9. PubMed ID: 3790351
    [No Abstract]   [Full Text] [Related]  

  • 35. Dystonia--L-dopa responsive or juvenile parkinsonism?
    Rondot P; Ziegler M
    J Neural Transm Suppl; 1983; 19():273-81. PubMed ID: 6583312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excretion of catecholamine metabolites in urine of neuroblastoma patients.
    Schweisguth O
    J Pediatr Surg; 1968 Feb; 3(1):118-20. PubMed ID: 5655558
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of urinary catecholamines with neuroblastoma in children by HPLC].
    Chang AW; Wu YM; Wu YJ; Xu D
    Wei Sheng Yan Jiu; 2006 Mar; 35(2):159-61. PubMed ID: 16758959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms--Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS).
    Deonna T
    Neuropediatrics; 1986 May; 17(2):81-5. PubMed ID: 3724992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopa-responsive dystonia.
    Nygaard TG; Marsden CD; Duvoisin RC
    Adv Neurol; 1988; 50():377-84. PubMed ID: 3041760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.